PACIRA BIOSCIENCES INC (PCRX) Stock Analyst Earnings Estimates
NASDAQ:PCRX - Nasdaq - US6951271005 - Common Stock
Full estimates are only available for subscribed users, you can see which data is available below.
Subscribed users also see more surprise data, now it is restricted to 4 quarters.
Examples of complete estimate data are available for MSFT and AAPL.
Registered users have access to more data. Please register or login for additional estimates and surprises .
| 2021 | 2022 | 2023 | 2024 | 2025 | 2026 | 2027 | 2028 | 2029 | 2030 | 2031 | 2032 | ||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue YoY % growth | 541.5M 26.05% | 666.8M 23.14% | 674.978M 1.23% | 707.57M 4.83% | 722.85M 2.16% | 807.3M 11.68% | 748.81M -7.25% | 715.92M -4.39% | 501.79M -29.91% | 450.17M -10.29% | 357.05M -20.69% | 245.96M -31.11% | |
| EBITDA YoY % growth | 161.3M 100.62% | 162.4M 0.68% | 162.897M 0.31% | 223.99M 37.50% | 227.09M 1.38% | 301.09M 32.59% | 324.74M 7.85% | 331.55M 2.10% | N/A | N/A | N/A | N/A | |
| EBIT YoY % growth | 132.8M 119.50% | 70.9M -46.61% | 87.323M 23.16% | 182.84M 109.38% | 221.98M 21.41% | 267.92M 20.70% | 277.77M 3.68% | 291.23M 4.85% | 157.56M -45.90% | 65.239M -58.59% | -64.258M -198.50% | -129.256M -101.15% | |
| Operating Margin | 24.52% | 10.63% | 12.94% | 25.84% | 30.71% | 33.19% | 37.09% | 40.68% | 31.40% | 14.49% | -18.00% | -52.55% | |
| EPS YoY % growth | 2.99 35.91% | 2.59 -13.38% | 2.92 12.74% | 3.16 8.09% | 3.22 1.98% | 3.83 19.02% | 4.18 9.16% | 4.46 6.59% | 2.14 -51.95% | 0.73 -65.71% | -1.68 -329.17% | -2.98 -76.97% |
All data in USD
| Q4 / 24 | Q1 / 25 | Q2 / 25 | Q3 / 25 | Q4 / 25 | |
|---|---|---|---|---|---|
| EPS Q2Q % growth | 0.80 -10.22% | 0.74 20.10% | 0.85 -4.85% | 0.80 0.81% | 0.88 9.53% |
| Revenue Q2Q % growth | 184.21M 1.64% | 163.82M -1.97% | 161.03M -9.55% | 150.98M -10.44% | 155.07M -15.82% |
| EBITDA Q2Q % growth | 58.902M -46.23% | 51.68M 54.08% | 58.185M -30.22% | 50.754M -36.15% | 57.869M -1.75% |
| EBIT Q2Q % growth | 52.159M 53.56% | 34.374M 127.42% | 37.383M -18.89% | 36.414M 65.90% | 40.596M -22.17% |
All data in USD
| Period | Reported | Estimate | Difference | Surprise |
|---|---|---|---|---|
| Q3 2024 Q2Q % growth | 0.79 9.72% | 0.72 | 0.07 | 9.93% |
| Q2 2024 Q2Q % growth | 0.89 14.10% | 0.71 | 0.18 | 24.81% |
| Q1 2024 Q2Q % growth | 0.62 16.98% | 0.64 | -0.02 | -2.59% |
| Q4 2023 Q2Q % growth | 0.89 11.25% | 0.90 | -0.01 | -1.23% |
| Q3 2023 Q2Q % growth | 0.72 12.50% | 0.80 | -0.08 | -9.96% |
| Q2 2023 Q2Q % growth | 0.78 52.94% | 0.77 | 0.01 | 0.88% |
| Q1 2023 Q2Q % growth | 0.53 -17.19% | 0.63 | -0.10 | -15.78% |
| Q4 2022 Q2Q % growth | 0.80 -17.53% | 0.85 | -0.05 | -5.48% |
| Q3 2022 Q2Q % growth | 0.64 -11.11% | 0.78 | -0.14 | -17.87% |
| Q2 2022 Q2Q % growth | 0.51 -33.77% | 0.87 | -0.36 | -41.29% |
| Q1 2022 Q2Q % growth | 0.64 20.75% | 0.85 | -0.21 | -24.60% |
| Q4 2021 Q2Q % growth | 0.97 11.49% | 0.92 | 0.05 | 5.31% |
| Q3 2021 Q2Q % growth | 0.72 5.88% | 0.67 | 0.05 | 8.04% |
| Q2 2021 Q2Q % growth | 0.77 541.67% | 0.75 | 0.02 | 2.59% |
| Q1 2021 Q2Q % growth | 0.53 | 0.65 | -0.12 | -18.19% |
| Q4 2020 Q2Q % growth | 0.87 55.36% | 0.84 | 0.03 | 3.48% |
| Q3 2020 Q2Q % growth | 0.68 41.67% | 0.64 | 0.04 | 5.69% |
| Q2 2020 Q2Q % growth | 0.12 -70.73% | 0.09 | 0.03 | 26.79% |
| Q1 2020 Q2Q % growth | 0.53 140.91% | 0.30 | 0.23 | 74.37% |
| Q4 2019 Q2Q % growth | 0.56 | 0.45 | 0.11 | 25.20% |
| Q3 2019 Q2Q % growth | 0.48 | 0.33 | 0.15 | 44.41% |
| Q2 2019 Q2Q % growth | 0.41 | 0.35 | 0.06 | 16.17% |
| Q1 2019 Q2Q % growth | 0.22 | 0.27 | -0.05 | -17.27% |
| Period | Reported | Estimate | Difference | Surprise |
|---|---|---|---|---|
| Q3 2024 Q2Q % growth | 168.573M 2.83% | 173.07M | -4.497M | -2.60% |
| Q2 2024 Q2Q % growth | 178.023M 5.05% | 175.95M | 2.073M | 1.18% |
| Q1 2024 Q2Q % growth | 167.117M 4.23% | 168.11M | -993K | -0.59% |
| Q4 2023 Q2Q % growth | 181.244M 5.37% | 185.3M | -4.056M | -2.19% |
| Q3 2023 Q2Q % growth | 163.926M -2.13% | 175.06M | -11.134M | -6.36% |
| Q2 2023 Q2Q % growth | 169.467M 0.04% | 178.1M | -8.633M | -4.85% |
| Q1 2023 Q2Q % growth | 160.341M 1.48% | 162.02M | -1.679M | -1.04% |
| Q4 2022 Q2Q % growth | 172M 8.04% | 176.97M | -4.97M | -2.81% |
| Q3 2022 Q2Q % growth | 167.5M 31.17% | 172.36M | -4.86M | -2.82% |
| Q2 2022 Q2Q % growth | 169.4M 24.93% | 173.71M | -4.31M | -2.48% |
| Q1 2022 Q2Q % growth | 158M 32.77% | 162.53M | -4.53M | -2.79% |
| Q4 2021 Q2Q % growth | 159.2M 21.53% | 159.54M | -340K | -0.21% |
| Q3 2021 Q2Q % growth | 127.7M 8.68% | 132.98M | -5.28M | -3.97% |
| Q2 2021 Q2Q % growth | 135.6M 79.60% | 134.58M | 1.02M | 0.76% |
| Q1 2021 Q2Q % growth | 119M 12.58% | 121.66M | -2.66M | -2.19% |
| Q4 2020 Q2Q % growth | 131M 7.03% | 134.2M | -3.2M | -2.38% |
| Q3 2020 Q2Q % growth | 117.5M 12.23% | 118.05M | -550K | -0.47% |
| Q2 2020 Q2Q % growth | 75.5M -26.41% | 73.906M | 1.594M | 2.16% |
| Q1 2020 Q2Q % growth | 105.7M 15.77% | 104.22M | 1.48M | 1.42% |
| Q4 2019 Q2Q % growth | 122.4M | 123.71M | -1.31M | -1.06% |
| Q3 2019 Q2Q % growth | 104.7M | 107.48M | -2.78M | -2.59% |
| Q2 2019 Q2Q % growth | 102.6M | 102.46M | 140K | 0.14% |
| Q1 2019 Q2Q % growth | 91.3M | 94.034M | -2.734M | -2.91% |
| Next Q (1 month) | Next Q (3 month) | Next Year (1 month) | Next Year (3 month) | |
|---|---|---|---|---|
| EPS | 0% | -2.95% | 0% | 1.81% |
| Revenue | 0% | -1.64% | -0.1% | 0.06% |